New York State Teachers Retirement System Has $44.94 Million Stock Holdings in Axon Enterprise, Inc $AXON

New York State Teachers Retirement System trimmed its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 62,616 shares of the biotechnology company’s stock after selling 1,191 shares during the quarter. New York State Teachers Retirement System owned about 0.08% of Axon Enterprise worth $44,936,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Hemington Wealth Management lifted its position in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares during the period. Whipplewood Advisors LLC increased its holdings in Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after buying an additional 27 shares during the period. Darwin Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at approximately $37,000. NewSquare Capital LLC lifted its holdings in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after acquiring an additional 25 shares during the period. Finally, Washington Trust Advisors Inc. lifted its holdings in shares of Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock worth $46,000 after acquiring an additional 17 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In other news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Monday, December 8th. The shares were sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the transaction, the president owned 249,502 shares in the company, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total value of $6,190,100.00. Following the completion of the sale, the chief executive officer owned 3,100,997 shares of the company’s stock, valued at $1,919,548,152.97. The trade was a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 60,540 shares of company stock worth $34,684,738. Company insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on AXON shares. Morgan Stanley lowered their price objective on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. Wall Street Zen lowered Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Needham & Company LLC restated a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research report on Wednesday, September 24th. UBS Group decreased their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Finally, Northcoast Research raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a report on Tuesday, January 6th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Trading Up 3.1%

NASDAQ AXON opened at $631.69 on Monday. The company has a market cap of $49.85 billion, a price-to-earnings ratio of 199.90, a price-to-earnings-growth ratio of 19.89 and a beta of 1.41. Axon Enterprise, Inc has a twelve month low of $469.24 and a twelve month high of $885.91. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The business’s fifty day moving average is $572.86 and its 200 day moving average is $687.38.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. During the same period in the previous year, the company earned $1.45 EPS. Axon Enterprise’s revenue for the quarter was up 30.6% on a year-over-year basis. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.